$100M Delaware Vaginal Mesh Verdict
June 4, 2015
On May 28, 2015, a Delaware jury returned its verdict in favor of the plaintiff in the amount of $100 million ($25 million in compensatory damages and $75 million in punitive damages) against Boston Scientific Corporation, the manufacturer of the transvaginal mesh that was implanted in the plaintif[...]
Continue Reading
First Risperdal Trial In Philadelphia Results In $2.5M Verdict
March 8, 2015
On February 24, 2015, a Philadelphia jury returned its verdict in favor of the plaintiff in the amount of $2.5 million in the first of about 1,250 pending Risperdal cases to go to trial in Philadelphia. The month-long trial was followed by about one and a half days of jury deliberations before 11 o[...]
Continue Reading
$5.7M California Transvaginal Mesh Verdict Against Ethicon
March 7, 2015
On March 5, 2015, a California jury returned a $5.7 million verdict against Ethicon, Inc., which is a Johnson & Johnson company, in a transvaginal mesh lawsuit filed by a woman who was implanted with Ethicon’s transvaginal mesh device in 2011 to treat her stress urinary incontinence. The[...]
Continue Reading
Intrathecal Pain Pump Malfunction
February 25, 2015
On January 9, 2015, a Texas man filed a product liability and negligence lawsuit against the manufacturer of his implanted morphine pump, alleging that the morphine pump was defectively designed, defectively manufactured, and that the placement of the morphine pump was negligent because there was no[...]
Continue Reading
Actos Defense Verdict In Maryland Upheld On Appeal
January 29, 2015
In an unreported decision of the Court of Special Appeals of Maryland dated December 4, 2014, the Court upheld a defense verdict in favor of the manufacturer of Actos, a FDA-approved prescription medication used to treat type 2 diabetes, in a lawsuit filed on behalf of the estate of a man who died[...]
Continue Reading
Pharmaceutical Company Recalls Empty Gabapentin Capsules
December 5, 2014
On November 21, 2014, the pharmaceutical company Aurobindo Pharma USA announced its voluntary recall of a particular lot (GESB14011-A, expiration date 12/2015) of its Gabapentin Capsules, USP 300 mg 100-count bottles because the lot has been found to contain some empty capsules. The capsules have[...]
Continue Reading
